Objective To investigate the clinical efficacy and safety of intravenous injection of low-dose versus high-dose gamma globulin combined with glucocorticoid pulse therapy in the treatment of children with moderate/severe acute Guillain-Barré syndrome (GBS). Methods A total of 100 children with moderate/severe acute GBS were randomly assigned to low-dose group (n=48) and high-dose group (n=52). The children in the low-dose and high-dose groups were treated with 0.2 g/ (kg·d) and 0.4 g/ (kg·d) gamma globulin respectively combined with methylprednisolone. The two groups were compared in terms of the time to improvements of symptoms after treatment, serum levels of inflammatory factors, proportion of children undergoing invasive ventilation, treatment response rate, and adverse events. Results After 5 days of treatment, the low- and high-dose groups had significant reductions in serum levels of tumor necrosis factor-α, interleukin-6, and C-reactive protein, and there were no significant differences in the reductions of these markers between the two groups. There were no significant differences between the two groups in the time to recovery of respiratory muscle paralysis, time to an improvement in muscle strength of one grade, time to recovery of sensory disturbance, and length of hospital stay. There was no significant difference in the treatment response rate between the low- and high-dose groups (90% vs 92%). There were also no significant differences in the incidence rates of pyrexia, headache, nausea, and palpitation between the two groups. Conclusions Low-dose versus high-dose gamma globulin combined with methylprednisolone pulse therapy have comparable clinical efficacy and safety in the treatment of children with moderate/severe acute GBS.
Key words
Guillain-Barré /
syndrome /
Gamma globulin /
Glucocorticoid /
Inflammatory factor /
Child
References
[1] 何雪桃, 王丽娟, 陈洁玲, 等. 大剂量丙种球蛋白治疗吉兰-巴雷综合征相关因素分析[J]. 中国神经免疫学和神经病学杂志, 2014, 21(1):9-11.
[2] 朱记军, 侍海存, 周桂龙. 不同剂量丙种球蛋白对急性吉兰-巴雷综合征疗效的比较[J]. 临床荟萃, 2009, 24(16):1409-1411.
[3] Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome[J]. Cochrane Database Syst Rev, 2014, (9):CD002063.
[4] 饶雪梅, 麦朗君, 李丽华. 激素联合丙种球蛋白治疗小儿格林巴利综合征的疗效观察[J]. 重庆医学, 2012, 41(17):1739-1740.
[5] 王坤亮, 朱家攀. 大剂量丙种球蛋白联合甲基强的松龙治疗急性格林巴利综合征36例疗效观察[J]. 中国伤残医学, 2014, 22(4):139.
[6] 王晓慧, 邹丽萍, 吴沪生, 等. 不同类型儿童吉兰-巴雷综合征的临床特点及治疗随访研究[J]. 中华儿科杂志, 2011, 49(8):583-586.
[7] 耿娜, 张金彪, 仲伟斌, 等. 大剂量丙种球蛋白静脉注射治疗急性期格林-巴利综合征的临床疗效[J]. 中国医学创新, 2015, 12(32):65-68.
[8] Zhang G, Massaad CA, Gao T, et al. Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury[J]. Exp Neurol, 2016, 282:49-55.
[9] van Koningsveld R, Schmitz PI, Meché FG, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome:randomised trial[J]. Lancet, 2004, 363(9404):192-196.
[10] 周劲松. 大剂量免疫球蛋白联合甲泼尼龙治疗急性格林巴利综合征的临床疗效[J]. 中国现代药物应用, 2012, 6(2):1-2.
[11] 杨翠容, 余小兰. 丙种球蛋白联合糖皮质激素治疗格林巴利综合征患者的护理[J]. 中国临床护理, 2012, 4(5):386-388.
[12] 江利敏. 激素联合小剂量丙种球蛋白治疗慢性格林-巴利综合征患者的疗效分析[J]. 中华脑科疾病与康复杂志(电子版), 2012, 2(1):53-56.
[13] Kerr J, Quinti I, Eibl M, et al. Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in Europe[J]. Front Immunol, 2014, 5:629.
[14] 杨丹琪, 吴云. 格林-巴利综合征发病机制中相关细胞因子的作用[J]. 国际免疫学杂志, 2015, 38(6):596-598.
[15] Vinod KV, Kumar M, Nisar KK. High dose intravenous immunoglobulin may be complicated by myocardial infarction[J]. Indian J Crit Care Med, 2014, 18(4):247-249.
[16] Elovaara I, Hietaharju A. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?[J]. Acta Neurol Scand, 2010, 122(5):309-315.
PDF(1428 KB)
